Rhabdomyolysis and Acute Kidney Injury Requiring Dialysis as a Result of Concomitant Use of Atypical Neuroleptics and Synthetic Cannabinoids
The use of synthetic cannabinoids (SCBs) is associated with many severe adverse effects that are not observed with marijuana use. We report a unique case of a patient who developed rhabdomyolysis and acute kidney injury (AKI) requiring dialysis after use of SCBs combined with quetiapine. Causes for...
Saved in:
Main Authors: | Aiyu Zhao, Maybel Tan, Aung Maung, Moro Salifu, Mary Mallappallil |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | Case Reports in Nephrology |
Online Access: | http://dx.doi.org/10.1155/2015/235982 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Paliperidone Inducing Concomitantly Syndrome of Inappropriate Antidiuretic Hormone, Neuroleptic Malignant Syndrome, and Rhabdomyolysis
by: Jaspinder Kaur, et al.
Published: (2016-01-01) -
QT and QTc in Male Patients with Psychotic Disorders Treated with Atypical Neuroleptics
by: Mario Miniati, et al.
Published: (2017-01-01) -
Neuroleptic Malignant Syndrome (NMS) on Clozapine with a Potential Atypical Interaction with Paliperidone
by: Paras Agarwal, et al.
Published: (2021-01-01) -
The Wide and Unpredictable Scope of Synthetic Cannabinoids Toxicity
by: Jose Orsini, et al.
Published: (2015-01-01) -
Brugada Phenocopy Type 1 Secondary to Synthetic Cannabinoids
by: Mohammad Amro, et al.
Published: (2020-01-01)